Applications Published 30 August 2000
Published: 26-Feb-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Novel oral dosage form for carvedilol
Boehringer Mannheim Pharmaceuticals-SmithKline Beecham Corp Limited Partnership 1030651*Production of multivesicular liposomes
Depotech Corp 1030652*Dintiroaniline liposomal formulations and processes for their preparation
Instituto Nacional de Engenhaira e Technologia Industrial/Instiuto de Biotecnologia, Qunimca Fina e Tecnologias Alimentares 1030653*Omeprazole formulation
Andrx Pharmaceuticals 1030654*Administering active substances by using the capsid produced out of the polyoma virus VP1 protein
November AG 1030656*Prolamin-plant polar lipid combination, preparation method and applications
Laboratoires La Vipharm 1030657*Method of building and maintaining bone
Eli Lilly 1030658*(+)-Ephedrine as a sympathomimetic drug
Warner-Lambert 1030659*A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof
Sam Yang Company 1030660*Treatment of T-helper cell type 2 mediated immune diseases with retinoid antagonists
F Hoffmann-La Roche 1030662*Treatment of fibromyalgia and related disorders
Designed Nutritional Products 1030663*Pharmaceutical compsns containing zafirlukast
AstraZeneca 1030664*Therapeutic uses of quinoline derivatives
Aventis Pharmaceuticals 1030664*Novel use of compounds for antipruritic activity
SmithKline Beecham 1030666*Use of mirtazapine for treating sleep apneas
Akzo Nobel 1030667*Penetration enhancing and irritation reducing systems
Cellegy Pharamceuticals 1030668*Progestogen-antiprogestogen regimens
Akzo Nobel 1030669*Use of vitamin D derivatives to enhance efficacy of cytotoxic agents
University of Pittsburgh of the Commonwealth System of Higher Education 1030670*Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as Alzheimer's disease
Sanofi-Synthelabo 1030671*Method for treating attention-defecit disorder
Merck 1030672*Use of ketolides for preparing arterial thrombitic complications related to atherosclerosis
Hoechst Marion Roussel 1030673*Method for treatment of tumours and tumour cells using (ex vivo) activated T cells
Arch Development Corp 1030674*Treatment of hematologic disorders
The General Hospital Corp 1030675*Bonding of cartilaginous matrices using isolated chondrocytes
The General Hospital Corp 1030676*Synergetic oral compsn combining sulphuric chondroitin acid and/or DNA with hydroxyproline
Pierre Fabre Dermo-Cosmetique 1030677*High throughput method for functionally classifying proteins indentified using a genomics approach
3-Dimensional Pharmaceuticals 1030678*Compsns and methods for promoting internalisation and degradation of urokinase-type plaminogen activator
The Trustees of the University of Pennsylvania 1030679*Treatment of Karposi's sarcoma with IL-12
Genetics Institute; The United States Government as represented by the Department for Health and Human Services 1030680*Method and compsns for inhibiting angiogenesis and treating cancer
The Wistar Institute of Anatomy and Biology 1030681*Preparations for the treatment of metabolic syndrome containing human growht hormone in combination with a cortisol synthesis inhibitor
Cortendo 1030682*Secretory leukocyte protease inhibitor dry powder pharmaceutical compsns
Amgen 1030683*Modified antibodies with enhanced ability to elicit an anti-idiotype response
Euro-Celtique 1030684*Essential bacterial genes and their use
Millennium Pharmaceuticals 1030685*Essential bacterial genes and their use
Millennium Pharmaceuticals 1030685*Cosmetic or dermopharmaceutical compsn in the form of beads and methods for preparing same
Ioulalen, Karim; Raynal, Rosanne 1030687*Method for decreasing self-association of polypeptides
Alza Corp 1030688*Complex between carageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compsns
Eurand International 1030689*Benzocyclohetene derivatives
Fujisawa Pharmaceuticals 1030834*Urea derivatives and their use as integrin inhibitors
AstraZeneca 1030835*Hydroxamic and carboxylic acid having MMP and TNF inhibitory activities
Darwin Discoveries 1030836*Lutein to zeaxanthin isomerisation process
Bioquimex Reka 1030837*Method of synthesis of pyrrole amides
Pfizer 1030838*Use of alkylated iminosugars to treat multidrug resistance
GD Searle 1030839*Cyclic amine derivatives and their use as drugs
Teijin 1030840*Process for the preparation of 1,4-dihydropyridines and compounds used in this process
A/S GEA Farmaceutisk 1030841*Metalloprotease inhibitors
British Biotech Pharmaceuticals 1030842*Compounds which inhibit tryptase activity
Array Biopharmaceuticals 1030844*Heterocyclic compounds having MMP and TNF inhibitory activity
Darwin Discovery1030845*Method for producing triazolinthion derivatives
Bayer 10308487*Azoline derivatives
Novartis 1030850*Oxazolidinone derivatives and pharmaceutical compsns
Pharmacia & Upjohn 1030852*Adenosine A1 receptor ligands
Glaxo Group 1030856*Adenosine A1 receptor agonists
Glaxo Group 1030857*Method to diagnose and treat pathological conditions resulting from deficient ion transport
Yale University 1030858*DNA regulatory element for the expression of transgenes in neurons of the mouse forebrain
The Trustees of Columbia University 1030860*Viral clearance process
Ortho Diagnostics Systems 1030862*
